Quick Telecast
Expect News First

US FDA delays decision on Moderna’s Covid-19 vaccine for adolescents, United States News & Top Stories

0 147


WASHINGTON (REUTERS) – The US health regulator is delaying its decision on authorising Moderna’s Covid-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation, the Wall Street Journal reported on Friday (Oct 15), citing people familiar with the matter.

Moderna’s shares fell nearly 2% to $326.25 in midday trading after the report.

The US Food and Drug Administration (FDA) has been looking into the risk of myocarditis among younger men vaccinated with Moderna’s shot, especially compared with Pfizer’s vaccine, after certain Nordic countries limited use of the shot, the Wall Street Journal report said.

The agency has not yet determined whether there is heightened risk, the report added.

Earlier this month, Finland, Sweden and Denmark paused the use of Moderna’s Covid-19 shot for younger males due to reports of the side effect, myocarditis, in men.

The Danish Health Agency, however, later said the vaccine was available to under-18s, and that a statement on Wednesday suggesting a suspension had, in fact, been a miscommunication.

The FDA and Moderna did not immediately respond to requests for comment.




WASHINGTON (REUTERS) – The US health regulator is delaying its decision on authorising Moderna’s Covid-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation, the Wall Street Journal reported on Friday (Oct 15), citing people familiar with the matter.

Moderna’s shares fell nearly 2% to $326.25 in midday trading after the report.

The US Food and Drug Administration (FDA) has been looking into the risk of myocarditis among younger men vaccinated with Moderna’s shot, especially compared with Pfizer’s vaccine, after certain Nordic countries limited use of the shot, the Wall Street Journal report said.

The agency has not yet determined whether there is heightened risk, the report added.

Earlier this month, Finland, Sweden and Denmark paused the use of Moderna’s Covid-19 shot for younger males due to reports of the side effect, myocarditis, in men.

The Danish Health Agency, however, later said the vaccine was available to under-18s, and that a statement on Wednesday suggesting a suspension had, in fact, been a miscommunication.

The FDA and Moderna did not immediately respond to requests for comment.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Quick Telecast is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

buy kamagra buy kamagra online